These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4624665)

  • 21. [Studies on thiacetazone resistance of tubercle bacilli. II. The relation between virulence in guinea-pigs and thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 Apr; 46(4):83-7. PubMed ID: 4102104
    [No Abstract]   [Full Text] [Related]  

  • 22. [Methods of determining the bacteriostatic activity of the blood and the primary drug resistance of mycobacteria in pulmonary tuberculosis].
    Bibik NF
    Probl Tuberk; 1980 Feb; (2):63-6. PubMed ID: 6769111
    [No Abstract]   [Full Text] [Related]  

  • 23. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of sensitivity of tubercle bacilli to pyrazinamide].
    Woźniak-Dubla S; Tomaszkiewicz L
    Gruzlica; 1973 Jan; 41(1):9-13. PubMed ID: 4631383
    [No Abstract]   [Full Text] [Related]  

  • 25. [The Mycobacteria Working Group: Investigation of resistance of tuberculosis bacteria in Germany 1991 and 1992].
    Urbanczik R
    Pneumologie; 1994 Jan; 48(1):28-9. PubMed ID: 8153116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possibilities of advances in the determination of drug resistance of tubercle bacilli].
    Buraczewska M
    Gruzlica; 1971 Aug; 39(8):729-37. PubMed ID: 4999630
    [No Abstract]   [Full Text] [Related]  

  • 27. [Considerations on drug-resistent tuberculosis patients admitted to G. Saint-Bois Hospital during the years 1966 to 1970].
    Piñeyro JA; Bazerque E; Fossemalle JR; Tarallo NH
    Hoja Tisiol; 1971; 28(1-2):77-88. PubMed ID: 5006266
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sensitivity of tubercle bacilli to pyrazinamide determined on the basis of their sensitivity to nicotinamide].
    Tatar J
    Gruzlica; 1974 Aug; 42(8):765-71. PubMed ID: 4277273
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bacteriological and clinical studies of sensitivity test (symposium)].
    Ogawa M; Osaki T; Oike Y; Kimura Z; Matsui T
    Kekkaku; 1970 Nov; 45(11):399-403. PubMed ID: 4991832
    [No Abstract]   [Full Text] [Related]  

  • 31. [Statistical evaluation of the dependence of chemotherapeutical success upon the frequency of bacteriological resistance tests].
    Kühler F
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):106-9. PubMed ID: 4980953
    [No Abstract]   [Full Text] [Related]  

  • 32. [The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
    Khomenko AG; Chesak OI; Biazov TA; Chaikina TN
    Probl Tuberk; 1972; 50(10):28-32. PubMed ID: 4633557
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 34. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the resistance ratio and proportion methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis.
    Tansuphasiri U; Subpaiboon S; Rienthong S
    J Med Assoc Thai; 2001 Oct; 84(10):1467-76. PubMed ID: 11804258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of dimethyl sulfoxide on tubercle bacilli resistant to INH].
    Ropek M; Pawlowska I; Szydlowska T
    Gruzlica; 1971 Aug; 39(8):738-41. PubMed ID: 4999631
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Occurrence and clinical importance of drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis].
    Kuznetsova EE
    Probl Tuberk; 1970; 48(9):39-43. PubMed ID: 4996495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.